Tsegaye L, Huston P, Milliken R, Hanniman K, Nesbeth C, Noad L
Schulich School of Medicine and Dentistry, Western University, London, ON.
Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, OttawaON.
Can Commun Dis Rep. 2016 Nov 3;42(11):223-226. doi: 10.14745/ccdr.v42i11a01.
On September 21, 2016, the United Nations General Assembly held a high-level meeting on antimicrobial resistance (AMR). Participating political leaders committed to coordinate action across the human and animal health, agriculture and environmental sectors and to work at national, regional and international levels with the public sector, private sector, civil society and all other relevant actors, including the public. The objective of this article is to outline how the Public Health Agency of Canada (PHAC) has been working to address AMR in Canada. PHAC has used a One Health approach and has been working at the federal level with other government departments and nationally with the provinces, territories, professional organizations and other key players to address AMR. To date, the federal response has focused on surveillance, stewardship and innovation across multiple sectors, including human health, animal health, regulatory actions and research. PHAC is currently working with the provinces and territories as well as key experts in the field to develop a pan-Canadian AMR Framework and subsequent action plan that will outline best practices and approaches to AMR across human and animal health. The Framework will build on previous work done by PHAC and the federal/provincial/territorial Pan-Canadian Public Health Network Council, and recognizes the research expertise in Canada, the need to ensure actions are based on evidence, and to combat AMR through infection prevention and control. The three articles in this issue are examples of the foundational work that has been done federally by PHAC, in developing the Canadian AMR Surveillance System (CARSS), and nationally, through task groups of the Public Health Network Council, in identifying where to strengthen human surveillance of AMR and best practices for stewardship in the human health care system. While we remain in an early stage of national, coordinated AMR action, momentum is building to ensure Canada can respond to this global health threat with a One Health approach involving multiple sectors at local, national and international levels that are all well-aligned with the World Health Organization Global Action Plan.
2016年9月21日，联合国大会召开了关于抗微生物药物耐药性（AMR）的高级别会议。与会的政治领导人承诺在人类与动物卫生、农业及环境领域协调行动，并在国家、区域和国际层面与公共部门、私营部门、民间社会及所有其他相关行为体（包括公众）开展合作。本文的目的是概述加拿大公共卫生局（PHAC）如何致力于应对加拿大的抗微生物药物耐药性问题。PHAC采用了“同一健康”方法，并一直在联邦层面与其他政府部门合作，在全国范围内与各省、地区、专业组织及其他关键行为体合作，以应对抗微生物药物耐药性问题。迄今为止，联邦层面的应对措施集中在多个领域的监测、管理及创新上，这些领域包括人类健康、动物健康、监管行动及研究。PHAC目前正与各省、地区以及该领域的关键专家合作，制定一项泛加拿大抗微生物药物耐药性框架及后续行动计划，该计划将概述人类与动物健康领域抗微生物药物耐药性的最佳做法和应对方法。该框架将以PHAC以及联邦/省/地区泛加拿大公共卫生网络理事会之前开展的工作为基础，并认可加拿大的研究专业知识，认识到有必要确保行动以证据为依据，并通过感染预防与控制来对抗抗微生物药物耐药性。本期的三篇文章是PHAC在联邦层面开展的基础工作的实例，这些工作包括开发加拿大抗微生物药物耐药性监测系统（CARSS），以及在全国范围内通过公共卫生网络理事会的各任务组，确定在哪些方面加强人类抗微生物药物耐药性监测以及人类医疗保健系统中管理的最佳做法。虽然我们仍处于国家协调的抗微生物药物耐药性行动的早期阶段，但各方正在形成合力，以确保加拿大能够采用“同一健康”方法应对这一全球健康威胁，该方法涉及地方、国家和国际层面的多个部门，且所有这些部门都与世界卫生组织全球行动计划保持高度一致。
